Melqart Asset Management (Uk) LTD Takeda Pharmaceutical CO LTD Transaction History

Melqart Asset Management (Uk) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $20.3 Million - $31.6 Million	-1,557,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $1.95 Million - $2.4 Million	-115,350 Reduced 6.9%	1,557,000 $30.7 Million
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $522,452 - $581,976	32,350 Added 1.97%	1,672,350 $28.8 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $2.63 Million - $3.26 Million	158,863 Added 10.73%	1,640,000 $29 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $24.7 Million - $31.9 Million	1,481,137 New	1,481,137 $30.2 Million

338

68.6M

1.72M

178K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.6B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Melqart Asset Management (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Melqart Asset Management (Uk) LTD with notifications on news.